Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 Next >
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
Tags Health care industry Business News Biotech and Pharmaceuticals
From CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
Tags Business US: News Biotechnology
From CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
Tags Eisai Co Ltd Business News Biotech and Pharmaceuticals
From CNBC.com News
Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
Tags Breaking News: Markets Eisai Co Ltd DraftKings Inc
From CNBC.com News
Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more
Tags Bloom Energy Corp Meta Platforms Inc stocks
From CNBC.com News
Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
Tags Pharmaceuticals Science Biogen Inc
From CNBC.com News
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
Tags World News Health care industry Eisai Co Ltd
From CNBC.com News
Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
Tags Urban Outfitters Inc Breaking News: Markets Goldman Sachs BDC Inc
From CNBC.com News
FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
Tags Epidemics Biotechnology Business
From CNBC.com News
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
Tags Biotech and Pharmaceuticals Business News Eisai Co Ltd
From CNBC.com News
Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
Tags Magellan Midstream Partners LP Oil and Gas Eli Lilly and Co
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags U/S/ Economy Policy Alzheimer's disease
From CNBC.com News
Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
Tags Business Finance Economy
From CNBC.com News
Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments
Tags Biotech and Pharmaceuticals Eisai Co Ltd Business News
From CNBC.com News
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
Tags Health care industry World News Biotech and Pharmaceuticals
From CNBC.com News
Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
Tags U/S/ Economy Disease outbreaks Congress
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
Tags Business US: News Biotechnology
From CNBC.com News
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
Tags Biotechnology US: News Medication
From CNBC.com News
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
Tags Pharmaceuticals Breaking news Biotechnology
From CNBC.com News
Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study
Tags Biotechnology US: News Pharmaceuticals
From CNBC.com News
FDA advisors reject Biogen's ALS drug for rare and aggressive form of the disease
Tags Biotech and Pharmaceuticals Biotechnology Health care industry
From CNBC.com News
FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease
Tags Biogen Inc Breaking News: Business Companies
From CNBC.com News
Veterans' Health will cover Alzheimer's treatment Leqembi for some patients
Tags Breaking News: Business US Economy Health & Science
From CNBC.com News
FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
Tags Coronavirus Epidemics US: News
From CNBC.com News
Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
Tags World News Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Stocks making the biggest moves midday: Deere, Airbnb, AutoNation, Moderna and more
Tags Business Roku Inc Economy
From CNBC.com News
Senators call on Medicare to offer broad coverage of Alzheimer's treatments as public pressure grows
Tags Coronavirus Epidemics Business
From CNBC.com News
Maker of promising Alzheimer's drug Leqembi expects full FDA approval this summer, expanded Medicare coverage
Tags Pandemics Politics US Top News and Analysis
From CNBC.com News
Stocks making the biggest moves premarket: Kraft Heinz, Paramount, Airbnb, Tripadvisor and more
Tags Berkshire Hathaway Inc Devon Energy Corp Generac Holdings Inc
From CNBC.com News
FDA approves Alzheimer's drug that slowed cognitive decline in clinical trial
Tags U/S/ Economy Policy Disease outbreaks
From CNBC.com News
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.